盐酸缬更昔洛韦片的售价多少呢？

Clinical studies conducted in AIDS patients infected with CMV retinitis have shown that valganciclovir hydrochloride tablets and intravenous ganciclovir are equally effective in the induction treatment of CMV retinitis. In the study, patients with newly diagnosed CMV retinitis were randomly assigned to the valganciclovir hydrochloride tablet group or the intravenous ganciclovir group for induction therapy. The proportion of patients with progression of CMV retinitis at week 4 was the same in both groups. After induction therapy, both groups of patients in the study continued to receive maintenance therapy with valganciclovir hydrochloride tablets 900 mg per day. Among patients who received induction therapy with valganciclovir hydrochloride tablets or intravenous ganciclovir tablets followed by maintenance therapy with valganciclovir hydrochloride tablets, the mean (median) time from randomization to progression of CMV retinitis was: 226 (160) days and 219 (125) days.

The therapeutic effect of Valganciclovir Hydrochloride Tablets is so remarkable, then how much does it cost?

Valganciclovir hydrochloride tablets are already on the market in China. Patients can buy this drug in domestic hospitals or regular pharmacies. Due to the patent restrictions of the original drug, the price of the tablets is relatively expensive. The domestic valganciclovir hydrochloride tablets have a specification of 450mg-60 tablets/box and sell for about US$2,250.

In addition, patients can also buy cheap Indian valganciclovir hydrochloride tablets. The specifications of Indian valganciclovir hydrochloride tablets are 450mg*60 tablets/box, and the price is about US$750. Due to the floating exchange rate, the price is not fixed. Please consult the medical companion for the specific price.

Usage and dosage: 1. Induction treatment of CMV retinitis. For patients with active CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. 2. Maintenance treatment of CMV retinitis. After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis. 3. Prevention of CMV infection in transplant patients. For kidney transplant patients, the recommended tablet dose is 900 mg (two 450 mg tablets) once daily, starting within 10 days after transplantation and continuing until 200 days after transplantation. For patients who have received a solid organ transplant other than a kidney, the recommended dose is 900 mg (two 450 mg tablets) once daily, starting within 10 days after transplantation and continuing until 100 days after transplantation.